Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Follow-Up Questions
Cosmos Health Inc (COSM)'in P/E oranı nedir?
Cosmos Health Inc 'in P/E oranı N/A 'dir
Cosmos Health Inc 'in CEO'su kimdir?
Mr. Grigorios Siokas 2016 'den beri şirketle birlikte olan Cosmos Health Inc 'in Chairman of the Board 'ıdır.
COSM hissesinin fiyat performansı nasıl?
COSM 'in mevcut fiyatı 0.945 'dir, son işlem günde 1.4% increased etti.
Cosmos Health Inc için ana iş temaları veya sektörler nelerdir?
Cosmos Health Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Cosmos Health Inc 'in piyasa değerlemesi nedir?
Cosmos Health Inc 'in mevcut piyasa değerlemesi $28.5 'dir
Cosmos Health Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Cosmos Health Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
